Gritstone bio (GRTS)
(Delayed Data from NSDQ)
$0.66 USD
+0.01 (1.44%)
Updated Jul 25, 2024 04:00 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Income Statements
Fiscal Year end for Gritstone bio Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 16 | 20 | 48 | 4 | 4 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 16 | 20 | 48 | 4 | 4 |
Selling & Adminstrative & Depr. & Amort Expenses | 156 | 140 | 123 | 110 | 102 |
Income After Depreciation & Amortization | -140 | -120 | -75 | -106 | -98 |
Non-Operating Income | 5 | 2 | 0 | 1 | 4 |
Interest Expense | 4 | 1 | 0 | 0 | 0 |
Pretax Income | -138 | -120 | -75 | -105 | -94 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -138 | -120 | -75 | -105 | -94 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -138 | -120 | -75 | -105 | -94 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -133 | -114 | -68 | -99 | -95 |
Depreciation & Amortization (Cash Flow) | 6 | 7 | 7 | 7 | 3 |
Income After Depreciation & Amortization | -140 | -120 | -75 | -106 | -98 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 115.53 | 90.92 | 78.89 | 37.79 | 33.56 |
Diluted EPS Before Non-Recurring Items | -1.20 | -1.32 | -0.95 | -2.79 | -2.81 |
Diluted Net EPS (GAAP) | -1.20 | -1.32 | -0.95 | -2.79 | -2.81 |
Fiscal Year end for Gritstone bio Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 1.74 | 10.38 | 1.57 | 1.96 |
Cost Of Goods | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | NA | 1.74 | 10.38 | 1.57 | 1.96 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 41.54 | 40.86 | 40.17 | 37.69 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -39.80 | -30.48 | -38.60 | -35.73 |
Non-Operating Income | NA | 0.71 | 0.87 | 1.16 | 1.46 |
Interest Expense | NA | 1.30 | 1.22 | 0.99 | 0.99 |
Pretax Income | NA | -40.39 | -30.82 | -38.43 | -35.26 |
Income Taxes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -40.39 | -30.82 | -38.43 | -35.26 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -40.39 | -30.82 | -38.43 | -35.26 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 118.39 | 118.53 | 115.34 | 114.93 |
Diluted EPS Before Non-Recurring Items | NA | -0.34 | -0.26 | -0.33 | -0.31 |
Diluted Net EPS (GAAP) | NA | -0.34 | -0.26 | -0.33 | -0.31 |